1. Home >
  2. M&A >
  3. Divestiture >
  4. United States >
  5. California >
  6. Avant Diagnostics Acquires Amarantus Diagnostics

M&A Deal Summary

Avant Diagnostics Acquires Amarantus Diagnostics

On May 12, 2016, Avant Diagnostics acquired life science company Amarantus Diagnostics from Amarantus BioScience Holdings

Acquisition Highlights
  • This is Avant Diagnostics’ 2nd transaction in the Life Science sector.
  • This is Avant Diagnostics’ 2nd transaction in the United States.
  • This is Avant Diagnostics’ 1st transaction in California.

M&A Deal Summary
Date 2016-05-12
Target Amarantus Diagnostics
Sector Life Science
Buyer(s) Avant Diagnostics
Sellers(s) Amarantus BioScience Holdings
Deal Type Divestiture

Target

Amarantus Diagnostics

San Francisco, California, United States
Amarantus Diagnostics, Inc. is a medical diagnostic technology company that specializes in biomarker tests that are based on querying large panels of proteins with exquisite precision.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Avant Diagnostics

Scottsdale, Arizona, United States
Category Company
Founded 2009
Sector Life Science
DESCRIPTION

Avant Diagnostics, Inc. is a medical technology company based on the completion of the human genome sequencing project.

DEAL STATS #
Overall 2 of 2
Sector: Life Science M&A 2 of 2
Type: Divestiture M&A Deals 1 of 1
State: California M&A 1 of 1
Country: United States M&A 2 of 2
Year: 2016 M&A 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-05-12 Theranostics Health

Gaithersburg, Maryland, United States

Theranostics Health, Inc. is a developer of proteomic technologies for measuring the activation status of key signaling pathways that are instrumental in the development of companion diagnostics for molecular-targeted therapies.

Buy -

Seller(S) 1

SELLER

Amarantus BioScience Holdings

San Francisco, California, United States
Category Company
Founded 2008
Sector Life Science
Employees3
DESCRIPTION

Amarantus BioScience Holdings, Inc. is a biotechnology company developing treatments and diagnostics for diseases associated with neurodegeneration and protein misfolding-related apoptosis.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Divestiture M&A Deals 1 of 1
State: California M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2016 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2015-07-15 Cutanogen

Cincinnati, Ohio, United States

Cutanogen Corp. is a biotechnology company.

Buy -
Mergr

Solution for

Product

Company

Legal